Floatz logo

Therapeutic Asset Ratings

394 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
immunoglobulin G1-kappa, anti-[Homo sapiens CDH6(cadherin 6, K-cadherin (foetal kidney), cadherin 6 type 2)], humanized monoclonal antibody conjugated to deruxtecan, comprising a linker and a camptothecin derivative
Ovarian Cancer
Merck Sharp & Dohme LLCP1/2CC (47)
Levoleucovorin
Esophageal Cancer
Merck Sharp & Dohme LLCP1/2CC (47)
Lorazepam
Castration-Resistant Prostatic Cancer
Merck Sharp & Dohme LLCP1/2CC (47)
Lorazepam
Ovarian Cancer Recurrent
Merck Sharp & Dohme LLCP1/2CC (47)
mk-4830
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
mk-5684
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
Patritumab Deruxtecan
Esophageal Cancer
Merck Sharp & Dohme LLCP1/2CC (47)
Patritumab Deruxtecan
Gastroesophageal Junction Adenocarcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
Sacituzumab Tirumotecan
Esophageal Cancer
Merck Sharp & Dohme LLCP1/2CC (47)
Sacituzumab Tirumotecan
Gastroesophageal Junction Adenocarcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
Sacituzumab Tirumotecan
Urothelial Carcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
Vibostolimab
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN 4) (HUMAN-MUS MUSCULUS MONOCLONAL M3 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL M3 .KAPPA.-CHAIN, DIMER
Colorectal Cancer
Merck Sharp & Dohme LLCP2CC (46)
mk-1942
Alzheimer Disease
Merck Sharp & Dohme LLCP2CC (46)
mk-4830
Colorectal Cancer
Merck Sharp & Dohme LLCP2CC (46)
Vibostolimab
Colorectal Cancer
Merck Sharp & Dohme LLCP2CC (46)
Itraconazole
Alzheimer Disease
Merck Sharp & Dohme LLCP1CC (46)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Esophageal Cancer
Merck Sharp & Dohme LLCP1/2CC (46)
mk-4830
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLCP1/2CC (46)
Favezelimab
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP1/2CC (45)
Ifinatamab Deruxtecan
Metastatic Neoplasm
Merck Sharp & Dohme LLCP1/2CC (45)
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN 4) (HUMAN-MUS MUSCULUS MONOCLONAL M3 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL M3 .KAPPA.-CHAIN, DIMER
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP1/2CC (45)
immunoglobulin G1-kappa, anti-[Homo sapiens CDH6(cadherin 6, K-cadherin (foetal kidney), cadherin 6 type 2)], humanized monoclonal antibody conjugated to deruxtecan, comprising a linker and a camptothecin derivative
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP1/2CC (45)
Lorazepam
Metastasis
Merck Sharp & Dohme LLCP1/2CC (45)
mk-1045
Diffuse Large B-Cell Lymphoma
Merck Sharp & Dohme LLCP1/2CC (45)
Showing 301 to 325 of 394 assets
PreviousPage 13 of 16Next